In summary, we have identified for the first time that the oncomiR miR-362-5p directly targets GADD45a and indirectly regulates the P38 and JNK signalling pathways in CML. This evidence concerns the gene MAPK8 and chronic myelogenous leukemia, BCR-ABL1 positive.